These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16870095

  • 1. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.
    Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
    [Abstract] [Full Text] [Related]

  • 2. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, Shoenfeld Y.
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S, Misra R, Aggarwal A.
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [Abstract] [Full Text] [Related]

  • 5. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
    Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
    [Abstract] [Full Text] [Related]

  • 6. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 7. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [Abstract] [Full Text] [Related]

  • 8. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, Kiani A, Nicknam MH, Nazari B, Nikbin B.
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [Abstract] [Full Text] [Related]

  • 9. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
    Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, Montgomery DS, Binks MH, Wilson AG.
    Arthritis Res Ther; 2006 Jun; 8(4):R128. PubMed ID: 16859535
    [Abstract] [Full Text] [Related]

  • 10. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group.
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [Abstract] [Full Text] [Related]

  • 11. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
    Mouterde G, Lukas C, Goupille P, Flipo RM, Rincheval N, Daurès JP, Combe B.
    J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
    [Abstract] [Full Text] [Related]

  • 12. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R, Ren X, Jing R, Shen X, Chen J, Ju S, Yang C.
    Lab Med; 2015 Aug; 46(3):226-9. PubMed ID: 26199263
    [Abstract] [Full Text] [Related]

  • 13. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

  • 14. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK.
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [Abstract] [Full Text] [Related]

  • 15. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
    Reneses S, González-Escribano MF, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A.
    J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity.
    Sockalingam S, Khuan CS, Sthaneshwar P.
    Int J Rheum Dis; 2009 Sep; 12(3):211-5. PubMed ID: 20374348
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
    Lamerato L, Price K, Szymialis R, Eaddy M, Ogbonnaya A, Shih HC, Ahmad H.
    J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
    [Abstract] [Full Text] [Related]

  • 18. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
    de Siqueira MB, da Mota LM, Couto SC, Muniz-Junqueira MI.
    BMC Musculoskelet Disord; 2015 Jun 30; 16():159. PubMed ID: 26123215
    [Abstract] [Full Text] [Related]

  • 19. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G, Hollan I, Førre Ø, Wiik A, Mikkelsen K, Agewall S.
    Scand J Rheumatol; 2011 Nov 30; 40(6):422-7. PubMed ID: 22150462
    [Abstract] [Full Text] [Related]

  • 20. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
    Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M.
    Clin Rheumatol; 2007 Jan 30; 26(1):17-23. PubMed ID: 16538391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.